Even though this study was conducted in vitro, we have tested EHop-016 and MBQ-167 in mouse models of HER2+ breast cancer, and have demonstrated their utility as metastasis inhibitors [44, 46, 93]. This evidence concerns the gene ERBB2 and breast carcinoma.